ARTHROCARE CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-12-06: Form 8-K; Period of report 2011-12-02; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2011-12-02: Form 8-K; Period of report 2011-12-02; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2011-11-28: Form 8-K; Period of report 2011-11-28; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2011-11-02: Form 8-K; Period of report 2011-11-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-12-06 | 8-K | 2011-12-02 | 7.01 Regulation FD Disclosure | 7.01 On December 2, 2011, Bruce C. Prothro, our Senior Vice President and Chief Regulatory Officer, entered into a new prearranged trading plan to sell up to 32,273 shares of ArthroCare common stock in one or more open market transactions between January 3, 2012 and July 31, 2012. | a11-31121_18k.htm |
| 2011-12-02 | 8-K | 2011-12-02 | 7.01 Regulation FD Disclosure | 7.01 ArthroCare Corporation (“ArthroCare”) has entered a Settlement Agreement and Release (the “Settlement Agreement”) with Integon National Insurance Company, Integon General Insurance Corporation, Integon Indemnity Corporation, Integon Preferred Insurance Company, National General Insurance Company, and MIC General Insurance Corporation and its parents, subsidiaries, affiliates, officers, directors, employees and agents (collectively, “GMAC”) regarding prior claims for reimbursement made to GMAC related to cases in which letters of protection were held by ArthroCare’s subsidiary DiscoCare, Inc. Pursuant to the Settlement Agreement, GMAC and ArthroCare have each released the other generally from any claims, demands, losses and liabilities occurring prior to the date of the Settlement Agreement, other than third party claims. | a11-30939_18k.htm |
| 2011-11-28 | 8-K | 2011-11-28 | 7.01 Regulation FD Disclosure | 7.01 On November 28, 2011 ArthroCare Corporation (“ArthroCare”) issued a press release describing an agreement in principle to settle the private securities class action cases currently pending against ArthroCare. | a11-30480_18k.htm |
| 2011-11-02 | 8-K | 2011-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2011, ArthroCare Corporation, (the “Company”) issued a press release reporting the filing of its Form 10-Q for the quarter ended September 30, 2011 along with the Company’s results for the quarter ended September 30, 2011. | a11-28837_18k.htm |
| 2011-10-24 | 8-K | 2011-10-13 | 8.01 Other Events | 8.01 On October 13, 2011, the U.S. District Court for the Western District of Texas granted preliminary approval of a proposed Stipulation of Settlement of federal and state derivative actions involving ArthroCare as nominal defendent, set a date for a final settlement approval hearing, and ordered publication of the Notice of Derivative Settlement. | a11-28248_18k.htm |
| 2011-08-03 | 8-K | 2011-08-03 | 2.02 Results of Operations and Financial Condition | 2.02 On August 3, 2011, ArthroCare Corporation, (the “Company”) issued a press release reporting the filing of its Form 10-Q for the quarter ended June 30, 2011 along with the Company’s results for the quarter ended June 30, 2011. | a11-23358_18k.htm |
| 2011-07-01 | 8-K | 2011-06-30 | 8.01 Other Events | 8.01 On June 30, 2011, ArthroCare Corporation (“the Company”) sold the assets related to its Parallax® and Contour™ product lines to NeuroTherm, Inc. (“NeuroTherm”) for proceeds of $5.5 million in cash. | a11-16406_18k.htm |
| 2011-06-02 | 8-K | 2011-06-01 | 7.01 Regulation FD Disclosure | 7.01 On June 1, 2011, Andrew J. Miclot, our Senior Vice President and General Manager, ENT, entered into a new prearranged trading plan to sell up to 10,000 shares of ArthroCare common stock in one or more open market transactions between July 1, 2011 and December 1, 2011. | a11-13710_18k.htm |
| 2011-05-24 | 8-K | 2011-05-20 | 7.01 Regulation FD Disclosure | 7.01 On May 20, 2011, Jean Woloszko, our Chief Technology Officer and Senior Vice President of Research and Development, entered into a new prearranged trading plan to sell up to 85,739 shares of ArthroCare common stock in one or more open market transactions between May 20, 2011 and May 20, 2012. | a11-13124_18k.htm |
| 2011-05-16 | 8-K | 2011-05-12 | 5.07 Submission of Matters to a Vote of Security Holders | a11-12494_18k.htm | |
| 2011-05-02 | 8-K | 2011-05-02 | 2.02 Results of Operations and Financial Condition | 2.02 On May 2, 2011, ArthroCare Corporation, (the “Company”) issued a press release reporting the filing of its Form 10-Q for the quarter ended March 31, 2011 along with the Company’s results for the quarter ended March 31, 2011. | a11-11173_18k.htm |
| 2011-04-25 | 8-K | 2011-04-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 20, 2011, Mr. Sten I. Dahlborg gave notice of his resignation from his position as Senior Vice President and President, International Operations of ArthroCare Corporation (the “Company”). | a11-10840_18k.htm |
| 2011-04-06 | 8-K | 2011-04-04 | 1.01 Entry into a Material Definitive Agreement; 2.05 Costs Associated with Exit or Disposal Activities | 1.01 Entry into a Material Definitive Agreement. 2.05 The Company intends to consolidate certain portions of its California operations in Austin, Texas. | a11-9884_18k.htm |
| 2011-03-24 | 8-K | 2011-03-23 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 23, 2011, the Board of Directors of ArthroCare Corporation (the “Company”) adopted the Company’s 2011 Executive Officer Bonus Plan, a copy of which is attached hereto as Exhibit 10.1, which is a cash bonus plan in which all of the Company’s named executive officers are participants. | a11-8701_18k.htm |
| 2011-03-02 | 8-K | 2011-03-01 | 7.01 Regulation FD Disclosure | 7.01 On March 1, 2011, Peter L. Wilson, a member of our Board of Directors, entered into a new prearranged trading plan to sell 40,000 shares of ArthroCare common stock in one or more open market transactions between March 31, 2011 and June 1, 2011. | a11-7069_18k.htm |
| 2011-02-14 | 8-K | 2011-02-14 | 2.02 Results of Operations and Financial Condition | 2.02 On February 14, 2011, ArthroCare Corporation, (the “Company”) issued a press release reporting its filing of its Form 10-K for the year ended December 31, 2010. | a11-5685_28k.htm |
| 2011-02-10 | 8-K | 2011-02-09 | 8.01 Other Events | 8.01 On February 9, 2011, ArthroCare Corporation (the “Company”) announced that it has entered into a settlement with the United States Securities and Exchange Commission (“SEC”) that fully resolves the SEC investigation against the Company that was first reported on July 24, 2008. | a11-5685_18k.htm |